Reply to K.I. Pritchard

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2013-12, Vol.31 (35), p.4477-4479
Hauptverfasser:	Fontein, Duveken B Y, van de Velde, Cornelis J H
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Hormonal - adverse effects Antineoplastic Agents, Hormonal - therapeutic use Aromatase Inhibitors - adverse effects Aromatase Inhibitors - therapeutic use Breast Neoplasms - drug therapy Breast Neoplasms - pathology Disease-Free Survival Female Genital Diseases, Female - chemically induced Humans Kaplan-Meier Estimate Musculoskeletal Diseases - chemically induced Outcome Assessment (Health Care) - methods Outcome Assessment (Health Care) - statistics & numerical data Proportional Hazards Models Tamoxifen - adverse effects Tamoxifen - therapeutic use Vasomotor System - drug effects Vasomotor System - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!